Immune checkpoint inhibitors can be coadministered as a fixed-ratio combination (FRC) or administered as sequential infusions (ASI). Two randomized, open-label trials compared nivolumab + ipilimumab ...

First results of an open-label, single arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second line therapy in patients with ...

Brain signal decoders are increasingly being used in early clinical trials for rehabilitation and assistive applications such as motor control and speech decoding. As many Brain-Computer Interfaces ...

All season long, Robert Griffin III has provided plenty of colorful commentary on the Baltimore Ravens, the final of the three NFL teams he played for. The Ravens backfield combination of quarterback ...

48-week end-of-treatment data from the ongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination with PEG-IFNα ...

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...

The AMD University Program (AUP) empowers academics with AMD technologies to enhance teaching, enrich learning, and advance state-of-the-art research. Through strategic collaborations with academic ...

Quantum-dot Cellular Automata (QCA) is recognized in electronics for its low power consumption and high-density capabilities, emerging as a potential substitute for CMOS technology. GDI (Gate ...

Impact of time-of-day infusion of camrelizumab combined with chemotherapy on efficacy in advanced malignant tumors. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...